%20(1)-1024x576.jpg&w=2048&q=75)
MedNet EC-REP at MedTec Japan 2025 – Meet Us at Booth 3303
MedNet EC-REP GmbH is pleased to announce its participation as an exhibitor at MedTec Japan 2025, one of Asia’s leading trade shows for medical device design and manufacturing. The event will take place in Tokyo from April 9–11, 2025, bringing together industry experts, manufacturers, and regulatory professionals from around the world.
At Booth 3303, our representatives Stefan Selle and Dr. Juliana Jonitz will be available to meet with both existing clients and new medical device manufacturers looking to enter the European market. As a trusted Authorized Representative (EC-REP) and Regulatory Importer, we provide expert guidance on regulatory compliance, ensuring a smooth and successful market entry in the EU.
We look forward to discussing your specific needs and offering tailored solutions to support your business. To schedule a meeting with our team at MedTec Japan, please use our contact form.
See you in Tokyo!
Latest news
-250x250.jpg&w=256&q=75)
MedNet EC-REP at CMEF Shanghai 2025
We are pleased to announce that we will be exhibiting at the China International Medical Equipment Fair (CMEF) in Shanghai from April 8 to April 11, 2025.
New Revision of MDCG 2020-16 Guidance on IVD Classification: Key Updates in Version 4
The Medical Device Coordination Group (MDCG) has released Revision 4 of the "Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746" (MDCG 2020-16).
UK Updates Post-Market Surveillance Requirements for Medical Devices
The Medicines and Healthcare products Regulatory Agency (MHRA) has released updated guidance on post-market surveillance (PMS) requirements for medical devices in Great Britain.
-250x250.jpg&w=256&q=75)
ISO 15223-1 Amendment: EC-REP Symbol Changes to EU-REP
The International Organization for Standardization (ISO) has recently amended ISO 15223-1:2021, introducing a change from "EC-REP" to "EU-REP" for the European Authorized Representative symbol.
Swissmedic Highlights Post-Market Surveillance Obligations for Legacy Devices
Swissmedic has released findings from a recent focused action, underscoring the critical importance of robust Post-Market Surveillance (PMS) for all medical devices.
EU Publishes Second Revision of MDCG 2023-3: Key Updates for Manufacturers
The European Commission has released the second revision of the MDCG 2023-3 guidance document in January 2025. This update includes important clarifications in line with Regulation (EU) 2024/1860
EU Commission Updates Guidance on SARS-CoV-2 Test Classification
The In Vitro Diagnostic (IVD) expert panel of the European Commission has released new scientific advice regarding SARS-CoV-2.